Dr Reddys Laboratories (RDY) EPS (Diluted) (QoQ) (2009 - 2023)
Dr Reddys Laboratories (RDY) EPS (Diluted) (QoQ) (2009 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 5.33% |
| Mar 31, 2023 | 44.40% |
| Dec 31, 2022 | 76,973,584.21% |
| Jun 30, 2021 | 74.03% |
| Sep 30, 2020 | -172.48% |
| Jun 30, 2020 | 88.61% |
| Sep 30, 2019 | -152.29% |
| Jun 30, 2019 | 62.77% |
| Mar 31, 2019 | 49.20% |
| Dec 31, 2018 | -10.00% |
| Sep 30, 2018 | 1.45% |
| Jun 30, 2018 | 9.52% |
| Mar 31, 2018 | 43.88% |
| Dec 31, 2017 | -13.73% |
| Dec 31, 2016 | -43.53% |
| Mar 31, 2016 | 19.13% |
| Dec 31, 2015 | -11.36% |
| Sep 30, 2015 | -20.00% |
| Dec 31, 2014 | -15.31% |
| Mar 31, 2014 | -3.18% |